Ticker Hub
COYA — AI Analysis & Sentiment
3 recent AI-generated analyses for COYA. Sentiment and confidence insights updated continuously.
Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Coya Therapeutics' recent FDA Fast Track designation for COYA 302 and securing $11.1 million in funding significantly de-risk its clinical pipeline...
May 12, 2026Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
The publication of scientific data supporting COYA 302's mechanism in FTD is a positive step for Coya Therapeutics. This strengthens the rationale ...
Mar 18, 2026Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results
Coya Therapeutics has made significant clinical and financial progress in 2025, securing funding into the second half of 2027 and advancing key dru...
Mar 16, 2026